Nothing Special   »   [go: up one dir, main page]

Tsao et al., 2022 - Google Patents

Dual-Sensitive gold-nanocubes platform with synergistic immunotherapy for inducing immune cycle using NIR-mediated PTT/NO/IDO

Tsao et al., 2022

View HTML
Document ID
4797274176317149803
Author
Tsao H
Cheng H
Kuo C
Chen S
Publication year
Publication venue
Pharmaceuticals

External Links

Snippet

Currently, the combination therapies based on immunotherapy have been rapidly developed, but the response rate has not always increased as expected. Nano-platform has become a potential strategy which can trigger multi-functions to increase immunotherapeutic …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb

Similar Documents

Publication Publication Date Title
Hu et al. Core-shell magnetic gold nanoparticles for magnetic field-enhanced radio-photothermal therapy in cervical cancer
Xu et al. Loading of indocyanine green within polydopamine-coated laponite nanodisks for targeted cancer photothermal and photodynamic therapy
Riley et al. Evaluating nanoshells and a potent biladiene photosensitizer for dual photothermal and photodynamic therapy of triple negative breast cancer cells
Yang et al. A facile one-pot synthesis of versatile PEGylated platinum nanoflowers and their application in radiation therapy
Leung et al. Investigation of sub-100 nm gold nanoparticles for laser-induced thermotherapy of cancer
Santi et al. Endogenously-activated ultrasmall-in-nano therapeutics: Assessment on 3D head and neck squamous cell carcinomas
Tsao et al. Dual-Sensitive gold-nanocubes platform with synergistic immunotherapy for inducing immune cycle using NIR-mediated PTT/NO/IDO
Charest et al. Concomitant chemoradiation therapy with gold nanoparticles and platinum drugs co-encapsulated in liposomes
Rodrigues et al. Induction of immunogenic cell death by photodynamic therapy mediated by aluminum-phthalocyanine in nanoemulsion
Guo et al. Enhanced radiation therapy of gold nanoparticles in liver cancer
Ren et al. Homotypic cancer cell membranes camouflaged nanoparticles for targeting drug delivery and enhanced chemo-photothermal therapy of glioma
Feng et al. MXene quantum dot/zeolitic imidazolate framework nanocarriers for dual stimulus triggered tumor chemo-phototherapy
Yang et al. Rare-earth-doped calcium carbonate exposed to X-ray irradiation to induce reactive oxygen species for tumor treatment
Tan et al. Cell membrane-coated halloysite nanotubes for target-specific nanocarrier for cancer phototherapy
Liu et al. Near-infrared light-triggered nitric oxide nanogenerators for NO-photothermal synergistic cancer therapy
Wang et al. Influence of parameters on photodynamic therapy of Au@ TiO2–HMME core-shell nanostructures
Tan et al. Hollow mesoporous CeO2-based nanoenzymes fabrication for effective synergistic eradication of malignant breast cancer via photothermal–chemodynamic therapy
Huang et al. Injectable hydrogel for Cu2+ controlled release and potent tumor therapy
Kalyane et al. CD44-receptor targeted gold-doxorubicin nanocomposite for pulsatile chemo-photothermal therapy of triple-negative breast cancer cells
Zduniak et al. The assessment of the combined treatment of 5-ALA mediated photodynamic therapy and thalidomide on 4T1 breast carcinoma and 2H11 endothelial cell line
Han et al. Nanotechnology driven cancer chemoradiation: exploiting the full potential of radiotherapy with a unique combination of gold nanoparticles and bleomycin
Chang et al. High performance gold nanorods@ DNA self-assembled drug-loading system for cancer thermo-chemotherapy in the second near-infrared optical window
Xie et al. Carrier-free microspheres of an anti-cancer drug synthesized via a sodium catalyst for controlled-release drug delivery
Liu et al. Application of Self-Assembly Nanoparticles Based on DVDMS for Fenton-Like Ion Delivery and Enhanced Sonodynamic Therapy
Aljarrah et al. Advancing Photodynamic Therapy Efficiency on MCF-7 Breast Cancer Cells through Silica Nanoparticles-Safranin Encapsulation: In-Vitro Evaluation